Novo Nordisk CagriSema Shows 25.4% Mean Weight Loss in Early Responders
A post hoc analysis found 25.4% mean weight loss among early responders to Novo Nordisk's CagriSema.
A post hoc analysis found 25.4% mean weight loss among early responders to Novo Nordisk's CagriSema.